endogenous self-peptides guard immune privilege of the central nervous system immune - endogenous-opioid-peptides-are-called immune

eminence-marine-peptide-eye-cream

Endogenous Self-Peptides: Guardians of Central Nervous System Immune Privilege

The central nervous system (CNS) maintains a unique state of immune privilege, shielding it from potentially damaging inflammatory responses'Endogenous self-peptides guard immune privilege of the central nervous system. www.nature.com. 0. 5. 26. 4012 · · Explore Trending .... A recent groundbreaking study, "Endogenous self-peptides guard immune privilege of the central nervous system," published in Nature, reveals a critical mechanism by which this privilege is upheld: through the presentation of endogenous self-peptides. These self-peptides, derived from the CNS itself, play a vital role in communicating with and dampening autoreactive T cell responses, thereby ensuring a delicate balance between immune defense and self-tolerance within the CNS.

The Mechanism of CNS Immune Privilege

Historically, the immune privilege of the central nervous system was attributed to anatomical barriers like the blood-brain barrier and the absence of conventional lymphatic vessels.Endogenous self-peptides guard immune privilege of the ... However, the discovery that endogenous self-peptides are presented on Major Histocompatibility Complex (MHC) class II molecules on CNS cells significantly expands our understanding. This presentation acts as a continuous dialogue between the CNS and the immune system, specifically engaging regulatory T cells. These regulatory T cells, often unconventional in their response, are crucial for maintaining immune homeostasis and preventing autoimmune attacks against the brain and spinal cord.

Self-Peptides as Molecular Mediators

The research highlights that CNS-derived regulatory self-peptides are not merely passive bystanders but active mediators in maintaining immune privilege内源性自身肽维持中枢神经系统的免疫特性—小柯机器人 - 新闻. By binding to MHC-II molecules, these self-peptides signal to T cells, effectively instructing them to adopt a tolerant rather than an aggressive stance. This proactive suppression of autoreactive T cells is a sophisticated strategy to protect the delicate neural environment from inflammation, which can lead to neurodegeneration and functional deficitsEndogenous self-peptides guard immune privilege of the ....

Implications for Neuroinflammation and Disease

Understanding how endogenous self-peptides guard immune privilege has profound implications for diseases characterized by neuroinflammation, such as multiple sclerosis (MS) and Alzheimer's disease. In conditions like MS, the immune system mistakenly attacks myelin, a key component of the CNS. Research into myelin-derived self-peptides, for example, suggests that specific peptides can promote immune tolerance within the CNS and induce regulatory T cell responses. This points towards potential therapeutic strategies that could harness these self-peptides or modulate their presentation to re-establish immune tolerance and ameliorate disease progression.

Future Directions in Brain-Immune Interaction

The ongoing exploration of the brain-immune ecosystem, including the role of glymphatics and meningeal lymphatics in waste clearance and immune regulation, complements the findings on endogenous self-peptides. This integrated view suggests that the CNS employs a multi-faceted approach to immune control.CNS immune privilege: hiding in plain sight Future research will likely focus on identifying specific self-peptides involved in various CNS conditions, understanding how their presentation is altered in disease states, and developing targeted therapies that leverage these natural regulatory mechanisms to treat neurological disorders.作者：MW Kim·2025·被引用次数：38—This is a PDF file of a peer-reviewed paper that has been accepted for publication. Although unedited, the content has been subjected to ...